Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
students who are eager to develop and apply artificial intelligence techniques and mechanistic mathematical models to explore fundamental questions in biology. The PhD program is organized in partnership
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently
-
. More concretely your work package, for the preparation of a doctorate, contains: You mainly conduct research with to obtain a PhD. Subject: Enhancing decision-making through the development and
-
decision-making for an optimal energy system, with specific focus on cost-effectiveness, emission reduction, and social acceptability. D2ET will develop a comprehensive digital platform for planning energy
-
the genetic etiology and developing diagnostics and treatment methods for these diseases. Approaches range from human genetics, genomics, protein biochemistry and neuronal and glial cell biology to integrative
-
to arrange working at both host institutions (UAntwerp and KU Leuven), located ca. 50 km apart with a direct train connection in-between. What we offer We offer a doctoral scholarship for a period of 1 year
-
approaches, developed and employed in the Malysheva Lab, are required to reveal these mechanisms. With the proposed project we aim to bridge this gap in our knowledge of cis-regulatory mechanisms underlying
-
registration are available at the end of December on the website of the Funding Academy. TechTransfer or one of the IOF-Business developers can give feedback on the valorisation part of the project proposal
-
. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel insights into molecular
-
of the biology that underlies cancer initiation, progression and metastatic dissemination with the ultimate goal to develop more effective and specific anti-cancer (combination) therapies. CCB is currently